Browsing Tag
Upjohn
4 posts
Viatris Inc. announces divestitures in key business sectors: Comprehensive breakdown
Viatris Inc. (NASDAQ: VTRS), a frontrunner in global healthcare, has unveiled a series of divestitures in its business…
October 2, 2023
Granules India gets Venlafaxine ER Capsules FDA approval
Granules India has secured approval for its abbreviated new drug application (ANDA) for Venlafaxine Hydrochloride Extended-Release (ER) Capsules…
May 19, 2023
Marksans Pharma secures US FDA approval for multiple strengths of Pregabalin capsules in key neuropathic pain segment
Marksans Pharma wins US FDA approval for multi-strength Pregabalin capsules, targeting a USD 263M neuropathic pain market in the United States.
July 21, 2022
FTC grants conditional approval for Mylan’s acquisition of Upjohn: What this means for the pharma industry
The U.S. Federal Trade Commission (FTC) has granted conditional approval for Mylan’s acquisition of Upjohn, Pfizer’s off-patent branded…
October 31, 2020